Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0714 Ceftazidime and avibactam

J Codes (Drugs)

Also known as: ceftazidime/avibactam, Avycaz, cephalosporin/inhibitor combo

Ceftazidime and avibactam injection, a combination of third-generation cephalosporin with beta-lactamase inhibitor for multidrug-resistant gram-negative bacteria.

In Plain Language

advanced antibiotic for resistant bacteria; extended-spectrum resistant infection treatment

Clinical Context

Combination of ceftazidime with avibactam beta-lactamase inhibitor for extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL) resistant gram-negative bacteria.

RVU Information

CPT J0714 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

infectious diseasecritical carehospital medicine

Frequently Asked Questions

What is CPT code J0714?

CPT J0714 (Ceftazidime and avibactam) is a J Codes (Drugs) code. Ceftazidime and avibactam injection, a combination of third-generation cephalosporin with beta-lactamase inhibitor for multidrug-resistant gram-negative bacteria.

How is J0714 administered?

CPT J0714 is administered by a healthcare provider, typically via injection or infusion. Combination of ceftazidime with avibactam beta-lactamase inhibitor for extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL) resistant gram-negative bacteria. It is used by infectious disease, critical care, hospital medicine.

When is CPT J0714 used?

Combination of ceftazidime with avibactam beta-lactamase inhibitor for extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL) resistant gram-negative bacteria.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.